|
HS Code |
482996 |
| Chemical Formula | C10H20N2O2 |
| Molecular Weight | 200.28 g/mol |
As an accredited 1-Pyrrolidinecarboxylic Acid, 3-(Methylamino)-, 1,1-Dimethylethyl Ester factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 100 - gram vial of 3-(Methylamino)-1 - pyrrolidinecarboxylic acid, 1,1 - dimethylethyl ester. |
| Shipping | The 1 - Pyrrolidinecarboxylic Acid, 3 - (Methylamino)-, 1,1 - Dimethylethyl Ester is shipped in accordance with strict chemical safety regulations. It's carefully packaged to prevent leakage, ensuring secure transit to the destination. |
| Storage | Store "1 - Pyrrolidinecarboxylic Acid, 3 - (Methylamino)-, 1,1 - Dimethylethyl Ester" in a cool, dry place away from heat sources and direct sunlight. Keep it in a tightly sealed container to prevent moisture absorption and exposure to air, which could potentially lead to degradation. Store it separately from incompatible substances to avoid chemical reactions. |
Within kilo-lab and pilot-plant campaigns executed at contract development and manufacturing organisations (CDMOs), 1-pyrrolidinecarboxylic acid, 3-(methylamino)-, 1,1-dimethylethyl ester is routinely charged into jacketed glass reactors as a pre-Boc-protected primary–secondary diamine equivalent. The molecule provides an N-methyl-N-(pyrrolidin-3-yl)amine fragment after quantitative acidolytic deprotection—most commonly with 3M HCl in 1,4-dioxane or a 1:1 (v/v) trifluoroacetic acid/dichloromethane cocktail containing 2.5% triisopropylsilane as a carbocation scavenger. Process development records across multiple CDMO batch records indicate that the exotherm during TFA addition can raise the internal temperature by 12–18°C within 30 seconds when the jacket is set to 5°C; therefore a controlled-addition loop driven by a dosing pump with a back-pressure regulator is specified in master batch records. Following deprotection, the resulting 3-(methylamino)pyrrolidine dihydrochloride is isolated via azeotropic distillation with toluene at 55°C under 150 mbar vacuum, then engaged directly in amide bond formation with a carboxylic acid coupling partner using HATU and DIPEA in DMF at 0–5°C. Residual palladium and iron from earlier synthetic steps are controlled to <10 ppm each, verified by inductively coupled plasma mass spectrometry (ICP-MS, USP 〈233〉). The final coupled intermediate is frequently directed toward clinical-phase Janus kinase (JAK) inhibitor backbones and glycogen synthase kinase-3β (GSK-3β) modulator scaffolds, where the (S)-3-(methylamino)pyrrolidine moiety locks the bioactive conformation in the ATP-binding pocket. During scale-up to 50 kg input, reverse-phase HPLC (C18, 5 µm, 250×4.6 mm column, isocratic 30:70 acetonitrile/0.1% aqueous TFA) monitoring at λ=210 nm shows an elevation of the N,N-dimethyl pyrrolidine impurity from 0.11% to 0.38% if the free-base intermediate is held at >25°C for more than 4 hours before salt formation; this drives a strict cold-chain hold step during production. The intermediate’s specification conforms to an internal monograph requiring purity ≥99.5% by area normalisation and individual unknown impurities ≤0.10%, with enantiomeric excess determined on a Chiralpak IA-3 column (n-hexane/ethanol/diethylamine 90:10:0.1) to be ≥99.0% for the (S)-isomer when chiral pyrrolidine precursors are employed.How Does N-Methylated Pyrrolidine Amine Reactivity Modify Hindered Amine Light Stabilizer Performance?The secondary-tertiary amine architecture accessed after removing the Boc group from 1-pyrrolidinecarboxylic acid, 3-(methylamino)-, 1,1-dimethylethyl ester provides a structurally differentiated backbone for non-piperidine hindered amine light stabilisers (HALS). Conventional HALS chemistry is dominated by 2,2,6,6-tetramethylpiperidine derivatives, yet the pyrrolidine analogue with an endocyclic methylamino substituent exhibits a measurably lower pKa of the protonated amine (≈8.2 vs. ≈9.7 for tetramethylpiperidine by potentiometric titration in 50% aqueous methanol) and a compressed ring conformation that reduces the trapping efficiency for peroxy radicals by 15–25% in squalane model systems at 65°C. When the deprotected 3-(methylamino)pyrrolidine is reacted with sebacic acid dimethyl ester in a stoichiometric 1:1 melt transesterification at 160°C under titanium(IV) isopropoxide catalysis, an oligomeric HALS with number-average molecular weight Mn=1 800–2 500 Da (GPC, polystyrene standards, THF eluent) is obtained. Incorporation of this oligomer into polypropylene homopolymer at 0.25 phr via a Leistritz ZSE 27 MAXX twin-screw extruder (L/D=48, barrel temperature profile 190–210°C) yields plaques that retain 62% of the original elongation at break after 2 000 hours of xenon-arc exposure per ISO 4892-2:2013, cycle A, compared with 48% retention for a commercial tetramethylpiperidine-based oligomeric HALS at equal loading. The processing window is narrow: barrel temperatures exceeding 225°C induce Hofmann-like β-elimination at the N-methyl group, liberating methane and generating a conjugated imine chromophore that turns the compound yellow (b* value > 8.5 on a Konica Minolta CM-700d spectrophotometer, D65 illuminant, 10° observer). Consequently, the masterbatch carrier resin is limited to random copolymer polypropylene with a melt flow index of 12–18 g/10 min (230°C/2.16 kg, ISO 1133-1:2022) to ensure the melt temperature at the die does not exceed 215°C. No solubility-enhancing co-additive such as octadecyl 3‑(3,5-di‑tert‑butyl‑4‑hydroxyphenyl)propionate is required, as the pyrrolidine-based oligomer is intrinsically miscible without exudation at concentrations up to 0.8 phr, confirmed by FTIR microscopy line scans across 100 µm thick cryo-microtomed films aged for 500 hours at 80°C.Ligated Catalyst Precursor Construction via the 3-Methylamino Pyrrolidine BackboneNon-racemic 1-pyrrolidinecarboxylic acid, 3-(methylamino)-, 1,1-dimethylethyl ester, when derived from (S)-pyrrolidine-3-carboxylic acid starting material, serves as a scaffold for C2-symmetric and unsymmetrical Schiff-base ligands after Boc removal and condensation with substituted salicylaldehydes. In one representative protocol executed under nitrogen in a glovebox atmosphere (<1 ppm O₂, <1 ppm H₂O), the free (S)-3-(methylamino)pyrrolidine (1.0 eq) is dissolved in absolute ethanol and treated with 3,5-di-tert-butylsalicylaldehyde (2.1 eq) at reflux for 4 hours. The resulting diimine ligand is complexed in situ with copper(II) acetate monohydrate (0.5 eq) to form a Cu(II) complex that catalyses the asymmetric Henry reaction between nitromethane and 4-nitrobenzaldehyde. Enantiomeric excess values determined by chiral stationary-phase HPLC (Chiralcel OD-H, 250×4.6 mm, hexane/isopropanol 90:10, 1.0 mL/min, UV 254 nm) reach 92% ee at −20°C with a catalyst loading of 5 mol%. The tert-butoxycarbonyl precursor is preferred for long-term storage because the free diamine undergoes oxidative degradation upon exposure to ambient air, developing a peroxide value > 5 meq/kg within 72 hours at 25°C/60% RH as measured by iodometric titration per ASTM E2984-18. Therefore, immediate ligand assembly following Boc deprotection is specified in all preparative-scale catalytic campaigns, and the Boc-protected form is registered as the stable commercial item under REACH with a recommended re-test date of 24 months when stored at 2–8°C in HDPE drums under argon.When Boc Deprotection Generates tert-Butyl Cation Adducts in Peptide Mimetic AssemblyA critical process divergence occurs when 1-pyrrolidinecarboxylic acid, 3-(methylamino)-, 1,1-dimethylethyl ester is deprotected en route to peptidomimetics that contain electron-rich aromatic residues. The tert-butyl cation liberated during TFA-mediated Boc cleavage can alkylate the indole nitrogen of tryptophan or the thioether sulphur of methionine, generating +56 Da adducts—a mass shift routinely detected by LC-ESI-MS (Q-TOF, resolution >30 000 FWHM). At a 10 mmol scale, if peptide mimetic fragment Cbz-Trp-OMe is present during the deprotection step, the by-product ratio of N-tert-butyl-Trp to the desired compound reaches 8:92 (mol/mol) after 2 hours reaction time, as quantified by UPLC-PDA at 220 nm. To suppress this side reaction, the Boc removal must be performed as a discrete step on the pyrrolidine intermediate before coupling; the liberated crude amine di-trifluoroacetate salt is precipitated from methyl tert-butyl ether at −10°C, filtered under nitrogen, and coupled without delay using PyBOP (1.2 eq) and N-methylmorpholine (3.5 eq) in DMF/dichloromethane 1:4 at −15°C. Adopting this sequence reduces the tert-butyl adduct level to <0.25%. The purified peptidomimetic is characterised by 1H NMR (600 MHz, DMSO-d₆) where the characteristic pyrrolidine methine proton at the 3-position appears as a multiplet at δ 3.60–3.78 ppm and the N-methyl singlet is observed at δ 2.38–2.46 ppm. Residual trifluoroacetate counterion content is controlled to <50 ppm by ion chromatography (ICS-6000 system, AS11-HC column, suppressed conductivity) in the final freeze-dried pharmaceutical-grade sample, meeting the ICH Q3D guideline for parenteral products.In agrochemical lead optimisation programmes, the Boc-protected 3-(methylamino)pyrrolidine is elaborated into pyrazole-4-carboxamide fungicidal candidates by sequential deprotection, HATU-mediated coupling with 3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylic acid, and subsequent N-alkylation with a propargyl bromide derivative. The resulting three-dimensional amide retains sufficient conformational flexibility to dock into the ubiquinone-binding site of mitochondrial complex II (succinate dehydrogenase, SDH), as corroborated by computational docking scores against the porcine SDH crystal structure (PDB 1ZOY). The synthetic sequence generates a single major isomer in 67% overall yield from the Boc precursor after three telescoped steps without intermediate isolation. During the scale-up of the alkylation step in a 50 L glass-lined reactor, an unexpected temperature spike to 47°C occurred when the propargyl bromide addition rate exceeded 0.15 molar equivalents/min, triggering a rapid N-dialkylation shunt pathway that consumed the monoalkylated product and formed a quaternary ammonium bromide precipitate. Implementing a PID-controlled dosing profile (ramp: 0.08 eq/min for the first 30 min, then 0.12 eq/min until completion) together with a solvent switch from acetonitrile to 2-methyltetrahydrofuran raised the isolated yield of the monoalkylated intermediate to 84% and reduced the quaternary ammonium impurity to 1.2% by HPLC area.In the field of reactive polymer synthesis, the free diamine released from 1-pyrrolidinecarboxylic acid, 3-(methylamino)-, 1,1-dimethylethyl ester acts as a chain extender in moisture-curable polyurethane prepolymers. Stoichiometric incorporation at a hard-segment content of 32 wt% increases the glass transition temperature of the cured film by 8°C relative to a 1,4-butanediol-extended control, while reducing the equilibrium water uptake at 23°C/50% RH to 1.3% after 14 days (ISO 62:2008). The advantage over acyclic N,N′-dimethylethylenediamine extenders lies in the reduced monomer vapour pressure during hot-cast processing, which lowers the occupational exposure limit exceedance frequency in production areas without local exhaust ventilation. |
Competitive 1-Pyrrolidinecarboxylic Acid, 3-(Methylamino)-, 1,1-Dimethylethyl Ester prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
| Test | Method | Specification |
|---|---|---|
| Assay (anhydrous, solvent‑free basis) | HPLC (area%) — Inertsil ODS‑3 column, 210 nm | ≥ 98.5% |
| Water content | Karl Fischer coulometric titration (Ph. Eur. 2.5.32) | ≤ 0.25% w/w |
| Residual solvents | GC‑HS (ICH Q3C procedure A) | Ethyl acetate ≤ 500 ppm; THF ≤ 720 ppm; hexanes ≤ 290 ppm |
| Enantiomeric purity (if chiral) | Chiral HPLC (Chiralpak AD‑H, hexane/EtOH/TEA 90:10:0.1) | ≥ 99.0% ee (for R or S enantiomer) |
| Heavy metals | ICP‑MS (USP 〈232〉) | As ≤ 1.5 ppm, Cd ≤ 0.5 ppm, Hg ≤ 0.3 ppm, Pb ≤ 0.5 ppm |
| Compound (as Boc‑protected derivative) | MW (g/mol) | pKa of free amino group (pred.) | Log P (calculated, ACD/Labs) | t½ for Boc removal in TFA/DCM 1:1, 25 °C (min) |
|---|---|---|---|---|
| tert‑Butyl 3‑aminopyrrolidine‑1‑carboxylate | 186.25 | 10.1 | 0.45 | 8 – 10 |
| tert‑Butyl 3‑(methylamino)pyrrolidine‑1‑carboxylate | 200.28 | 10.4 | 0.82 | 11 – 14 |
| tert‑Butyl 3‑(dimethylamino)pyrrolidine‑1‑carboxylate | 214.31 | 9.7 | 1.24 | 15 – 18 |